<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">
  <title>Project Title</title>
  <link rel="icon" href="./favicon.ico" type="image/x-icon">

  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@shoelace-style/shoelace@2.16.0/cdn/themes/light.css" />
  <script type="module"
    src="https://cdn.jsdelivr.net/npm/@shoelace-style/shoelace@2.16.0/cdn/shoelace-autoloader.js"></script>

  <link rel="stylesheet" href="./index.css">

  <link rel="stylesheet" href="./components/team-member/team-member.css">
  <script type="module" src="./components/team-member/team-member.js"></script>

  <link rel="stylesheet" href="./components/table-of-content/table-of-content.css">

  <script type="module" src="./components/image/image-component.js"></script>

  <script type="module" src="./components/video/video.js"></script>

  <link rel="stylesheet" href="./components/references/references.css">

  <link rel="stylesheet" href="./components/scroll-to-top/scroll-to-top.css">
  <script src="./components/scroll-to-top/scroll-to-top.js"></script>

  <script src="./components/table-component/table-component.js"></script>

  <link href="https://unpkg.com/gridjs/dist/theme/mermaid.min.css" rel="stylesheet" />
</head>

<body>
  <div class="content">
    <h1>Project Title</h1>

    <!-- This is the team member component use to display details about your team members -->
    <div class="team-member-wrapper">
      <team-member avatar="assets/blackranger.png" name="Black" department="Mechanical Engineering"
        year="1993"></team-member>
      <team-member avatar="assets/yellowranger.png" name="Yellow" department="Computer Engineering"
        year="1993"></team-member>
      <team-member avatar="assets/redranger.png" name="Red" department="Electrical Engineering"
        year="1993"></team-member>
      <team-member avatar="assets/pinkranger.png" name="Pink" department="Biomedical Engineering"
        year="1993"></team-member>
      <team-member avatar="assets/blueranger.png" name="Blue" department="Chemical Engineering"
        year="1993"></team-member>
    </div>

    <!-- This is a divide from the shoelace library for aesthetic purpose -->
    <sl-divider></sl-divider>

    <!-- This is the table-of-content component use to define all of the link directly to each section -->
    <div class="table-of-content">
      <h2>Table of Contents</h2>
      <sl-tree>
        <sl-tree-item expanded>
          <a href="#Introduction">1. Introduction</a>
          <sl-tree-item>
            <a href="#Research-Context">Research Context</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#Problem-Statement">Problem Statement</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#Project-Objective">Project-Objective</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#Problem-Scope">Project Scope</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#Novelty-and-Contribution">Novelty and Contribution</a>
          </sl-tree-item>          
        </sl-tree-item>

        <sl-tree-item expanded>
          <a href="#Methodology">2. Methodology</a>
          <sl-tree-item>
            <a href="#sub-section-2-header-1">2.1. Sub-section Header 1</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#sub-section-2-header-2">2.2. Sub-section Header 2</a>
          </sl-tree-item>
        </sl-tree-item>

        <sl-tree-item expanded>
          <a href="#Results">3. Results</a>
          <sl-tree-item>
            <a href="#sub-section-2-header-1">2.1. Sub-section Header 1</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#sub-section-2-header-2">2.2. Sub-section Header 2</a>
          </sl-tree-item>
        </sl-tree-item>

        <sl-tree-item expanded>
          <a href="#Discussion">4. Discussion</a>
          <sl-tree-item>
            <a href="#sub-section-2-header-1">2.1. Sub-section Header 1</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#sub-section-2-header-2">2.2. Sub-section Header 2</a>
          </sl-tree-item>
        </sl-tree-item>

        <sl-tree-item expanded>
          <a href="#Future-works">5. Future Works</a>
          <sl-tree-item>
            <a href="#sub-section-2-header-1">2.1. Sub-section Header 1</a>
          </sl-tree-item>
          <sl-tree-item>
            <a href="#sub-section-2-header-2">2.2. Sub-section Header 2</a>
          </sl-tree-item>
        </sl-tree-item>

        <sl-tree-item>
          <a href="#references">References</a>
        </sl-tree-item>
      </sl-tree>
    </div>
    <sl-divider></sl-divider>

    <div>

      <!-- This is an example of what a section might look like -->
      <div id="Introduction">
        <h2> 1. Introduction </h2>
        <div id="Research-Context">
        <p>
          <b>Research Context.</b> Engineered immune-cell therapies have transformed oncology
          by demonstrating that synthetic genetic reprogramming can endow effector cells with
          potent, tumor-specific cytotoxicity [1]. Among these, chimeric antigen receptor (CAR)
          T-cell therapy stands as the most successful example—six products have gained 
          regulatory approval to date for the treatment of aggressive malignancies [2], such as
          relapsed or refractory B-cell lymphoma [3, 4] and multiple myeloma [5, 6]. This 
          approach harnesses a patient’s own immune system to selectively recognize and 
          eliminate tumor cells, overcoming limitations of traditional cancer treatments 
          such as surgery, radiotherapy, and chemotherapy, which often lack selectivity and 
          efficacy against advanced or disseminated disease. Reflecting its impact, the 
          global cell therapy market—estimated at US$25 billion in 2025—is projected to 
          exceed US$117 billion by 2034, driven by expansion into solid tumors [7], 
          autoimmune disorders, and infectious diseases.
        </p>
        <p>
          Despite these clinical successes, the field remains constrained by a fundamental
          manufacturing bottleneck. As of June 2023, more than 1300 clinical trials of CAR-T
          and related therapies were registered, approximately 93% of which employ autologous
          manufacturing pipelines [? ]. Such patient-specific production is logistically fragile and
          economically prohibitive (US$0.4–1 million per treatment), limiting access to roughly
          20% of prescribed patients [? ? ]. Moreover, in real-world settings, manufacturing
          delays are so severe that ∼ 7% of patients die before receiving their infusion [? ].
        </p>
        <p>
          The core challenge lies in the transfection of primary immune cells—a critical step
          for introducing chimeric receptors or enabling precise genome edits. Current 
          delivery modalities impose intrinsic trade-offs: (1) Viral vectors suffer from 
          limited cargo capacity (∼ 5–15 kb), risks of random genomic integration, 
          immunogenicity, and costly cGMP-scale production [? ? ]. (2) Bulk electroporation 
          requires extremely high electric fields (tens to hundreds of kVcm−1), causing 
          Joule heating, calcium dysregulation, and transcriptional perturbations that 
          compromise cell viability and function [? ]. Furthermore, current treatment relies 
          on centralized production models due to labor-intensive manual production and the 
          need to maintain consistent quality and minimize product variability. Additionally, 
          QA/QC protocols are implemented due to concerns from the viral nature of the 
          treatment. This contributes to long wait times and necessitates cryopreservation, 
          which can render some patients ineligible due to rapid deterioration in health and 
          reduction in CAR-T cell viability before infusion. Current solutions to address 
          these challenges include automated devices such as CliniMac’s Prodigy and
          Thermofisher CTS xenon system, but they are designed to produce one batch of dose per 
          cycle.
        </p>
        <p>
          With the U.S. FDA projecting 10–20 new cell and gene therapy approvals annually
          by 2025 and the allogeneic immune-cell therapy market expected to grow at a CAGR
          of ∼ 27.4%, there is an urgent need for scalable, non-viral, multipayload transfection
          technologies that preserve cellular integrity and integrate seamlessly into closed-loop
          automation.
          
        </p>
        </div>
        <div id="Problem-Statement">
        <p>
          <b>Probelm Statement.</b> This demand motivates a new manufacturing paradigm: a
          universal, automated bioreactor platform capable of producing off-the-shelf immune
          effector cells at scale—decoupled from viral intermediates, engineered for high
          throughput and low-perturbation delivery, and designed to accelerate the industrial
          translation of next-generation cell therapies.
        </p>
        </div>
        <div id="Project-Objective">
        <p>
          <b>Project Objective.</b> In this project, we aim to streamline and automate the
          transfection workflow for producing allogeneic immune cells. Current manufacturing
          pipelines for CAR-T therapy remain expensive, labour-intensive, and centralized, 
          creating high costs, quality variability, and long production cycles. By developing an
          integrated automated system, we seek to reduce production costs, ensure consistent
          product quality, and shorten vein-to-vein time—ultimately enabling decentralized and
          more accessible manufacturing of immune-cell therapies. Within the team, Tianmu
          will lead the development of the automation backbone, focusing primarily on the
          design and optimization of the media-transportation system. Celeste will concentrate
          on engineering the transfection module. Both subsystems will be jointly integrated
          into a cohesive automated platform.
        </p>
        </div>
        <div id="Project-Scope">
        <p>
          <b>Project Scope.</b> Because the central objective is automation, our validation 
          strategy emphasizes engineering performance rather than deep biological 
          characterization. Specifically, our target milestones are: (1) improved recovery 
          efficiency—minimizing residual volume and achieving a recovery rate greater than 50%; 
          (2) robust, stable, and controllable system operation with a total processing time below 
          10 minutes; and (3) low system-induced cell loss, maintaining cell viability above 70%
          when operating without electroporation. Initial testing will be performed using Jurkat 
          cells, an immortalized T-cell line with a rapid doubling time (approximately 1–2 days), 
          making it suitable for repeated prototyping cycles. The combined evaluation across 
          recovery, stability, and viability will determine whether the platform is ready for 
          downstream optimization toward bedside or on-bench automated manufacturing of immune cells.
        </p>
        <p>
          As an additional enhancement, we aim to incorporate experiments in vitro once the
          engineering benchmarks are met. This may include optimizing system parameters for
          transfection of primary human T cells using fluorescent dyes or non-functional protein
          cargo, thereby producing a prototype that is immediately ready for future biologically
          intensive refinement.
        </p>
        </div>
        <div id="Novelty-and-Contribution">
        <p>
          <b>Novelty and Contribution.</b> Our work presents three key advances over existing
          approaches: (1) We automate a non-viral transfection pipeline built on nanostructured
          interfaces that can be manufactured at comparatively low cost. The goal is
          to deliver a next-generation, scalable, and automated non-viral transfection 
          platform that can serve both clinical (bed-side) and research (on-bench) applications. No
          equivalent system currently exists on the market; our prototype therefore lays the
          foundational groundwork for a future universal immune-cell manufacturing device.
          (2) We expand our earlier single-well prototype into a 96-well system, increasing 
          production throughput by up to 96-fold. The redesigned platform incorporates standard
          laboratory consumables—including 96-well plates, pipette tips, and common medical
          springs—to ensure compatibility with existing laboratory workflows and enhance 
          clinical utility. (3) We introduce an innovative shift from media-based to 
          container-based transportation. This approach mitigates cell loss and residual 
          accumulation, two common issues in current bioreactor designs. By ensuring that cells are transferred in a
          highly preserved state, this method improves cell viability and significantly compresses
          the overall manufacturing timeline.
        </p>
        </div>

      </div>

      

        <!-- This is an example of how you might use the image component -->
        <!-- This is an example of how you might use the image component -->
        <image-component tag="image" source="assets/requirement.png"
          subtitle="Image 1: iDP suggested pathway"></image-component>
      </div>
    </div>


    <sl-divider></sl-divider>
    <div class = "content">
      <div id="Methodology">
        <h2>2. Methodology</h2>
        <p>
          Ornare arcu dui vivamus arcu felis bibendum ut tristique et. Mi proin sed libero enim sed faucibus turpis in
          eu. Odio ut sem nulla pharetra diam sit. Nibh cras pulvinar mattis nunc sed blandit libero. Lacus sed viverra
          tellus in hac habitasse platea dictumst vestibulum. At augue eget arcu dictum varius duis. Mauris ultrices
          eros in cursus turpis massa (Lindberg, 1967). Libero nunc consequat interdum varius sit amet mattis. Ut ornare
          lectus sit amet est placerat in egestas erat. Elementum curabitur vitae nunc sed. Proin nibh nisl condimentum
          id venenatis a condimentum vitae sapien (Chamberlin et al., 2008). Vitae tempus quam pellentesque nec nam
          aliquam sem.
        </p>
      </div>

      <div id="sub-section-2-header-1">
        <h3>2.1. Sub-section Header 1</h3>
        <p>
          Pellentesque nec nam aliquam sem et tortor consequat. Et netus et malesuada fames ac turpis egestas maecenas.
          Eu tincidunt tortor aliquam nulla facilisi. Nunc aliquet bibendum enim facilisis gravida. Elementum pulvinar
          etiam non quam lacus (Moll et al., 2011; Parker & Fox, 2010). Blandit cursus risus at ultrices mi. Arcu dui
          vivamus arcu felis bibendum ut tristique. Porttitor rhoncus dolor purus non enim praesent elementum facilisis.
          Mauris in aliquam sem fringilla. Non quam lacus suspendisse faucibus. Tristique senectus et netus et malesuada
          fames ac. <a href="#image">Link to the image above</a>
        </p>

        <!-- This is an example of how you might use the video component -->
        <video-component tag="rick" source="https://www.youtube.com/embed/dQw4w9WgXcQ"
          subtitle="Video: Never gonna give you up?"></video-component>
      </div>

      <div id="sub-section-2-header-2">
        <h3>2.2. Sub-section Header 2</h3>
        <p>
          Vitae proin sagittis nisl rhoncus mattis rhoncus urna neque viverra. Dignissim convallis aenean et tortor at
          risus viverra adipiscing. Facilisi nullam vehicula ipsum a arcu cursus. Adipiscing elit pellentesque
          habitant
          morbi tristique senectus et netus. Turpis massa tincidunt dui ut ornare lectus. Suspendisse sed nisi lacus
          sed. Diam volutpat commodo sed egestas egestas fringilla phasellus faucibus. Ut ornare lectus sit amet est
          placerat in egestas. Magna fringilla urna porttitor rhoncus. Imperdiet dui accumsan sit amet.
        </p>

        <!-- This is an example of how you might use the table component -->
        <table-component subtitle="Table: Demo table">
          <div id="table-1"></div>
        </table-component>
      </div>
    </div>

    <sl-divider></sl-divider>
    <div class = "content">
      <div id="Results">
        <h2>3. Results</h2>
        <p>
          Ornare arcu dui vivamus arcu felis bibendum ut tristique et. Mi proin sed libero enim sed faucibus turpis in
          eu. Odio ut sem nulla pharetra diam sit. Nibh cras pulvinar mattis nunc sed blandit libero. Lacus sed viverra
          tellus in hac habitasse platea dictumst vestibulum. At augue eget arcu dictum varius duis. Mauris ultrices
          eros in cursus turpis massa (Lindberg, 1967). Libero nunc consequat interdum varius sit amet mattis. Ut ornare
          lectus sit amet est placerat in egestas erat. Elementum curabitur vitae nunc sed. Proin nibh nisl condimentum
          id venenatis a condimentum vitae sapien (Chamberlin et al., 2008). Vitae tempus quam pellentesque nec nam
          aliquam sem.
        </p>
        <iframe src="Figures/Figure_1.pdf" width="100%" height="600px"></iframe>
        
      </div>

      <div id="sub-section-2-header-1">
        <h3>2.1. Sub-section Header 1</h3>
        <p>
          Pellentesque nec nam aliquam sem et tortor consequat. Et netus et malesuada fames ac turpis egestas maecenas.
          Eu tincidunt tortor aliquam nulla facilisi. Nunc aliquet bibendum enim facilisis gravida. Elementum pulvinar
          etiam non quam lacus (Moll et al., 2011; Parker & Fox, 2010). Blandit cursus risus at ultrices mi. Arcu dui
          vivamus arcu felis bibendum ut tristique. Porttitor rhoncus dolor purus non enim praesent elementum facilisis.
          Mauris in aliquam sem fringilla. Non quam lacus suspendisse faucibus. Tristique senectus et netus et malesuada
          fames ac. <a href="#image">Link to the image above</a>
        </p>

        <!-- This is an example of how you might use the video component -->
        <video-component tag="rick" source="https://www.youtube.com/embed/dQw4w9WgXcQ"
          subtitle="Video: Never gonna give you up?"></video-component>
      </div>

      <div id="sub-section-2-header-2">
        <h3>2.2. Sub-section Header 2</h3>
        <p>
          Vitae proin sagittis nisl rhoncus mattis rhoncus urna neque viverra. Dignissim convallis aenean et tortor at
          risus viverra adipiscing. Facilisi nullam vehicula ipsum a arcu cursus. Adipiscing elit pellentesque
          habitant
          morbi tristique senectus et netus. Turpis massa tincidunt dui ut ornare lectus. Suspendisse sed nisi lacus
          sed. Diam volutpat commodo sed egestas egestas fringilla phasellus faucibus. Ut ornare lectus sit amet est
          placerat in egestas. Magna fringilla urna porttitor rhoncus. Imperdiet dui accumsan sit amet.
        </p>

        <!-- This is an example of how you might use the table component -->
        <table-component subtitle="Table: Demo table">
          <div id="table-1"></div>
        </table-component>
      </div>
    </div>

    <sl-divider></sl-divider>
    <div class = "content">
      <div id="Discussion">
        <h2>4. Discussion</h2>
        <p>
          Ornare arcu dui vivamus arcu felis bibendum ut tristique et. Mi proin sed libero enim sed faucibus turpis in
          eu. Odio ut sem nulla pharetra diam sit. Nibh cras pulvinar mattis nunc sed blandit libero. Lacus sed viverra
          tellus in hac habitasse platea dictumst vestibulum. At augue eget arcu dictum varius duis. Mauris ultrices
          eros in cursus turpis massa (Lindberg, 1967). Libero nunc consequat interdum varius sit amet mattis. Ut ornare
          lectus sit amet est placerat in egestas erat. Elementum curabitur vitae nunc sed. Proin nibh nisl condimentum
          id venenatis a condimentum vitae sapien (Chamberlin et al., 2008). Vitae tempus quam pellentesque nec nam
          aliquam sem.
        </p>
      </div>      
      <iframe src="Figures/Figure_2.pdf" width="100%" height="600px"></iframe>

      <div id="sub-section-2-header-1">
        <h3>2.1. Sub-section Header 1</h3>
        <p>
          Pellentesque nec nam aliquam sem et tortor consequat. Et netus et malesuada fames ac turpis egestas maecenas.
          Eu tincidunt tortor aliquam nulla facilisi. Nunc aliquet bibendum enim facilisis gravida. Elementum pulvinar
          etiam non quam lacus (Moll et al., 2011; Parker & Fox, 2010). Blandit cursus risus at ultrices mi. Arcu dui
          vivamus arcu felis bibendum ut tristique. Porttitor rhoncus dolor purus non enim praesent elementum facilisis.
          Mauris in aliquam sem fringilla. Non quam lacus suspendisse faucibus. Tristique senectus et netus et malesuada
          fames ac. <a href="#image">Link to the image above</a>
        </p>

        <!-- This is an example of how you might use the video component -->
        <video-component tag="rick" source="https://www.youtube.com/embed/dQw4w9WgXcQ"
          subtitle="Video: Never gonna give you up?"></video-component>
      </div>

      <div id="sub-section-2-header-2">
        <h3>2.2. Sub-section Header 2</h3>
        <p>
          Vitae proin sagittis nisl rhoncus mattis rhoncus urna neque viverra. Dignissim convallis aenean et tortor at
          risus viverra adipiscing. Facilisi nullam vehicula ipsum a arcu cursus. Adipiscing elit pellentesque
          habitant
          morbi tristique senectus et netus. Turpis massa tincidunt dui ut ornare lectus. Suspendisse sed nisi lacus
          sed. Diam volutpat commodo sed egestas egestas fringilla phasellus faucibus. Ut ornare lectus sit amet est
          placerat in egestas. Magna fringilla urna porttitor rhoncus. Imperdiet dui accumsan sit amet.
        </p>

        <!-- This is an example of how you might use the table component -->
        <table-component subtitle="Table: Demo table">
          <div id="table-1"></div>
        </table-component>
      </div>
    </div>

    <div class = "content">
      <div id="Future-works">
        <h2>5. Future Works</h2>
        <p>
          Ornare arcu dui vivamus arcu felis bibendum ut tristique et. Mi proin sed libero enim sed faucibus turpis in
          eu. Odio ut sem nulla pharetra diam sit. Nibh cras pulvinar mattis nunc sed blandit libero. Lacus sed viverra
          tellus in hac habitasse platea dictumst vestibulum. At augue eget arcu dictum varius duis. Mauris ultrices
          eros in cursus turpis massa (Lindberg, 1967). Libero nunc consequat interdum varius sit amet mattis. Ut ornare
          lectus sit amet est placerat in egestas erat. Elementum curabitur vitae nunc sed. Proin nibh nisl condimentum
          id venenatis a condimentum vitae sapien (Chamberlin et al., 2008). Vitae tempus quam pellentesque nec nam
          aliquam sem.
        </p>
      </div>
      <iframe src="Figures/Figure_3.pdf" width="100%" height="600px"></iframe>

      <div id="sub-section-2-header-1">
        <h3>2.1. Sub-section Header 1</h3>
        <p>
          Pellentesque nec nam aliquam sem et tortor consequat. Et netus et malesuada fames ac turpis egestas maecenas.
          Eu tincidunt tortor aliquam nulla facilisi. Nunc aliquet bibendum enim facilisis gravida. Elementum pulvinar
          etiam non quam lacus (Moll et al., 2011; Parker & Fox, 2010). Blandit cursus risus at ultrices mi. Arcu dui
          vivamus arcu felis bibendum ut tristique. Porttitor rhoncus dolor purus non enim praesent elementum facilisis.
          Mauris in aliquam sem fringilla. Non quam lacus suspendisse faucibus. Tristique senectus et netus et malesuada
          fames ac. <a href="#image">Link to the image above</a>
        </p>

        <!-- This is an example of how you might use the video component -->
        <video-component tag="rick" source="https://www.youtube.com/embed/dQw4w9WgXcQ"
          subtitle="Video: Never gonna give you up?"></video-component>
      </div>

      <div id="sub-section-2-header-2">
        <h3>2.2. Sub-section Header 2</h3>
        <p>
          Vitae proin sagittis nisl rhoncus mattis rhoncus urna neque viverra. Dignissim convallis aenean et tortor at
          risus viverra adipiscing. Facilisi nullam vehicula ipsum a arcu cursus. Adipiscing elit pellentesque
          habitant
          morbi tristique senectus et netus. Turpis massa tincidunt dui ut ornare lectus. Suspendisse sed nisi lacus
          sed. Diam volutpat commodo sed egestas egestas fringilla phasellus faucibus. Ut ornare lectus sit amet est
          placerat in egestas. Magna fringilla urna porttitor rhoncus. Imperdiet dui accumsan sit amet.
        </p>

        <!-- This is an example of how you might use the table component -->
        <table-component subtitle="Table: Demo table">
          <div id="table-1"></div>
        </table-component>
      </div>
    </div>

    <!-- This is an example of how you can use the references component to create references -->
    <div id="references" class="references">
      <sl-divider></sl-divider>
      <h2>References</h2>
      <ul>
        <li>
          Brody, J. E. (2007, December 11). Mental reserves keep brain agile. The New York Times. Retrieved from
          http://www.dowjones.com/factiva/
        </li>
        <li>
          Chamberlin, J., Novotney, A., Packard, E., & Price, M. (2008, May). Enhancing worker well-being: Occupational
          health psychologists convene to share their research on work, stress, and health. Monitor on Psychology,
          39(5), 26-29.
        </li>
        <li>
          Jones, T. J., & Fields, N. (2003). Emotional quotient and personality. E-Journal of Applied Psychology, 2(2),
          38-45. Retrieved from http://ejournalappliedpsyc/index.php/ejap
        </li>
      </ul>
    </div>
  </div>

  <!-- This is the code to display the scroll to top button for ergonomic -->
  <!-- You can leave it as it is, or if you don't like its aesthetics you can also just delete it, -->
  <!-- but it might reduce the user experience. -->
  <sl-button class="scroll-to-top" variant="primary" size="medium" circle onclick="scrollToTop()">
    <sl-icon name="arrow-up" label="Settings"></sl-icon>
  </sl-button>

  <script src="https://unpkg.com/gridjs/dist/gridjs.umd.js"></script>
  <script type="module" src="./components/table-component/table-component.js"></script>
</body>

</html>

